To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCDC46andAXIN2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
374 supporting clones for gene CCDC46andAXIN2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC310584 cerebellum .a 1 to 317 1 to 317   tiling clone,   317/317
(100 %)
0 diff
(100 %id)
AK096929   .a 38 to 1845 1 to 1808   tiling clone, available from FLJ,   1808/1808
(100 %)
2 diff
(99.9 %id)
DA914291   .a 39 to 585 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
AK299075   .a 50 to 3444 1 to 3395 K551E E604G I900M tiling clone,   3395/3395
(100 %)
7 diff
(99.8 %id)
DC369663   .a 50 to 607 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
DA818048   .a 62 to 613 2 to 553   capped   552/558
(98 %)
3 diff
(99.5 %id)
DA124131 cerebellum .a 63 to 613 2 to 553   capped   552/569
(97 %)
1 diff
(99.9 %id)
DB049506 testis .a 63 to 634 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BE149117 head_neck .a 140 to 589 457 to 8     Submitted on the opposite strand 450/462
(97 %)
2 diff
(99.6 %id)
BE149129 head_neck .a 293 to 577 283 to 1     Submitted on the opposite strand 283/283
(100 %)
5 diff
(98.3 %id)
DB195102 trachea .a 970 to 1476 2 to 510   capped   509/510
(99 %)
3 diff
(99.5 %id)
DA760149   .a 1043 to 1589 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
AF458591 lung .a 1105 to 3164 12 to 2071   tiling clone,   2060/2076
(99 %)
10 diff
(99.6 %id)
BF352092 head_neck .a 1105 to 1486 12 to 394       383/394
(97 %)
6 diff
(98.5 %id)
AI978997 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1515 to 2009 499 to 5       495/499
(99 %)
1 diff
(99.8 %id)
BU507108 leiomyosarcoma, uterus .a 1519 to 2431 1 to 914   tiling clone,   914/915
(99 %)
12 diff
(98.7 %id)
CX872964 embryonic stem .a 1808 to 2600 1 to 793       793/832
(95 %)
0 diff
(100 %id)
BE082323 breast .a 1992 to 2339 12 to 360       349/360
(96 %)
7 diff
(98.1 %id)
BE082334 breast .a 2014 to 2334 31 to 351       322/351
(91 %)
7 diff
(98.1 %id)
AW275213 lung, two pooled squamous cell carcinomas .a 2077 to 2475 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AW275237 brain, three pooled meningiomas .a 2077 to 2475 399 to 1       399/399
(100 %)
0 diff
(100 %id)
DA101197 cerebellum .a 2202 to 2777 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
CD722629 eye, lacrimal gland .a 2280 to 2900 1 to 621       621/621
(100 %)
0 diff
(100 %id)
AA382922 testis .a 2323 to 2538 1 to 216       216/320
(67 %)
2 diff
(99.4 %id)
BG548160 lung .a 2372 to 2930 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
BM931966 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2419 to 2600 1 to 182   fully sequenced,   182/182
(100 %)
0 diff
(100 %id)
W46209 senescent fibroblast .a 2454 to 2973 14 to 538   fully sequenced,   525/538
(97 %)
16 diff
(97.1 %id)
BX097629 senescent fibroblast .a 2456 to 3151 1 to 698       696/698
(99 %)
1 diff
(99.9 %id)
R84858 liver and spleen .a 2536 to 2733 36 to 235       202/235
(85 %)
11 diff
(95.4 %id)
BQ017344 lung, Metastatic Chondrosarcoma .a 2536 to 3161 644 to 19   AAA   626/645
(97 %)
2 diff
(99.7 %id)
BM685007 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2544 to 3161 636 to 19   fully sequenced, AAA   618/618
(100 %)
2 diff
(99.7 %id)
EG328104 pooled .a 2546 to 2966 1 to 421       421/421
(100 %)
3 diff
(99.3 %id)
AI979276 pooled germ cell tumors .a 2591 to 3161 571 to 1       571/571
(100 %)
4 diff
(99.3 %id)
AI218590 pooled .a 2602 to 3162 553 to 3       551/564
(97 %)
10 diff
(98.3 %id)
AW269774 pooled .a 2623 to 3162 544 to 5       540/544
(99 %)
0 diff
(100 %id)
AW117497 pooled .a 2624 to 3164 546 to 6       541/546
(99 %)
0 diff
(100 %id)
CN260574 embryonic stem cells, cell lines H1, H7, andH9 .a 2640 to 3171 13 to 544       532/544
(97 %)
6 diff
(98.9 %id)
BE464015 pooled germ cell tumors .a 2676 to 3162 488 to 2       487/488
(99 %)
0 diff
(100 %id)
AW269767 pooled .a 2677 to 3159 490 to 8       483/490
(98 %)
0 diff
(100 %id)
BQ574747 Chondrosarcoma Grade II, Left Pelvis .a 2690 to 3437 766 to 19   AAA   748/748
(100 %)
1 diff
(99.9 %id)
DB518742 testis .a 2692 to 3161 1 to 470     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
BF057657 pooled germ cell tumors .a 2694 to 3162 470 to 2       469/470
(99 %)
0 diff
(100 %id)
AA039403 uterus .a 2720 to 3165 17 to 468   fully sequenced,   452/468
(96 %)
7 diff
(98.6 %id)
AA088596 uterus .a 2720 to 3116 15 to 412       398/412
(96 %)
1 diff
(99.8 %id)
CB998559 Blood vessels - aorta, basilar and artery .a 2723 to 3436 2 to 716       715/742
(96 %)
4 diff
(99.5 %id)
AA781351   .a 2743 to 3166 426 to 3       424/505
(83 %)
4 diff
(99.3 %id)
BG182178   .a 2745 to 3409 1 to 664       664/776
(85 %)
26 diff
(96.7 %id)
W28100 eye, retina .a 2749 to 3144 100 to 497       398/621
(64 %)
8 diff
(98.8 %id)
AI696076 pooled germ cell tumors .a 2756 to 3162 409 to 4       406/416
(97 %)
0 diff
(100 %id)
AI025502   .a 2757 to 3166 412 to 3       410/412
(99 %)
0 diff
(100 %id)
EC557178 Prostate .a 2758 to 2863 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
AW136955   .a 2797 to 3165 384 to 16   AAA   369/369
(100 %)
5 diff
(98.7 %id)
AI220590   .a 2802 to 3166 367 to 3       365/367
(99 %)
0 diff
(100 %id)
BG531260 embryonal carcinoma, testis .a 2814 to 3417 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
AA758981   .a 2823 to 3164 353 to 12       342/353
(96 %)
1 diff
(99.8 %id)
AA406069   .a 2830 to 3162 340 to 8       333/340
(97 %)
0 diff
(100 %id)
AI634149 pooled germ cell tumors .a 2832 to 3162 334 to 4       331/334
(99 %)
0 diff
(100 %id)
BG203878   .a 2835 to 3400 1 to 567       567/902
(62 %)
25 diff
(97.3 %id)
BG206537   .a 2835 to 3163 1 to 331   AAA   331/331
(100 %)
12 diff
(96.4 %id)
BG216568   .a 2835 to 3162 1 to 331       331/341
(97 %)
10 diff
(97.1 %id)
AA972182 pooled .a 2838 to 3169 334 to 3       332/334
(99 %)
0 diff
(100 %id)
AA628118   .a 2839 to 3163 340 to 16   AAA   325/328
(99 %)
1 diff
(99.7 %id)
N33500.
matches multiple genes
melanocyte .a 2840 to 3161 324 to 1     also hits gene MAGOHandC1orf123 324/347
(93 %)
2 diff
(99.5 %id)
BG191579   .a 2844 to 3161 1 to 317   AAA   317/317
(100 %)
8 diff
(97.5 %id)
TI_149274044   .a 2856 to 3441 727 to 139   AAA   589/969
(60 %)
47 diff
(95.2 %id)
AI215556 pooled .a 2858 to 3162 306 to 2       305/306
(99 %)
0 diff
(100 %id)
BG200923   .a 2871 to 3161 26 to 314   AAA   289/314
(92 %)
7 diff
(97.8 %id)
AI218587 pooled .a 2872 to 3162 293 to 3       291/293
(99 %)
0 diff
(100 %id)
W26315 eye, retina .a 2872 to 3322 465 to 17       451/469
(96 %)
7 diff
(98.6 %id)
W46210 senescent fibroblast .a 2912 to 3161 268 to 15   fully sequenced, AAA   254/254
(100 %)
3 diff
(98.9 %id)
N25525 melanocyte .a 2913 to 3097 1 to 193   fully sequenced,   193/193
(100 %)
1 diff
(99.5 %id)
AA701653 liver and spleen .a 2916 to 3437 522 to 1       522/522
(100 %)
1 diff
(99.9 %id)
AI766748 2 pooled tumors (clear cell type), Kidney .a 2926 to 3164 241 to 3       239/241
(99 %)
0 diff
(100 %id)
AA724549 pooled .a 2933 to 3164 235 to 4       232/235
(98 %)
0 diff
(100 %id)
AA778787 liver and spleen .a 2934 to 3437 505 to 1       505/505
(100 %)
2 diff
(99.7 %id)
AW628808 pooled .a 2970 to 3169 200 to 1       200/200
(100 %)
0 diff
(100 %id)
AW087598 pooled .a 3011 to 3164 159 to 6       154/159
(96 %)
0 diff
(100 %id)
AI281715 esophagus, squamous cell carcinoma .a 3036 to 3441 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
N20493 melanocyte .a 3067 to 3441 377 to 1   fully sequenced,   377/377
(100 %)
0 diff
(100 %id)
AA039283 uterus .a 3135 to 3437 303 to 1   fully sequenced,   303/303
(100 %)
1 diff
(99.7 %id)
R85787 liver and spleen .a 3227 to 3444 227 to 9       219/227
(96 %)
4 diff
(98.3 %id)
DC327965 caudate nucleus .b 1 to 566 1 to 566   tiling clone,   566/566
(100 %)
2 diff
(99.7 %id)
NM_145036.3   .b 1 to 3524 1 to 3524 exact RefSeq,   3524/3525
(99 %)
5 diff
(99.9 %id)
BM800563 leiomyosarcoma, uterus .b 6 to 909 4 to 910   available from MGC,   907/1036
(87 %)
18 diff
(98.3 %id)
BC037991 Uterus, leiomyosarcoma .b 15 to 1914 1 to 1900   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1900/1903
(99 %)
5 diff
(99.8 %id)
AA723963 parathyroid gland, parathyroid tumor .b 3303 to 3518 223 to 8   tiling clone,   216/223
(96 %)
0 diff
(100 %id)
BE889966 leiomyosarcoma, uterus .b 3343 to 3513 1 to 172   AAA   172/172
(100 %)
1 diff
(99.5 %id)
C20812   .b 3419 to 3517 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BC131805 PCR rescued clones .c 1 to 2847 1 to 2847 K524E tiling clone,   2847/2847
(100 %)
2 diff
(100.0 %id)
AK308888 brain .c 2651 to 4266 1 to 1616   tiling clone,   1616/1616
(100 %)
2 diff
(99.9 %id)
DC323863 brain .c 2651 to 3175 1 to 526       526/526
(100 %)
3 diff
(99.5 %id)
BU156663 leiomyosarcoma, uterus .c 2875 to 3707 1 to 836   tiling clone,   836/840
(99 %)
11 diff
(98.7 %id)
TI_927045594   .c 2897 to 3872 238 to 1209     Submitted on the opposite strand 972/1242
(78 %)
25 diff
(98.0 %id)
TI_927045834   .c 2897 to 3741 239 to 1097     Submitted on the opposite strand 859/1286
(66 %)
6 diff
(99.6 %id)
TI_927046058   .c 2897 to 3921 240 to 1261     Submitted on the opposite strand 1022/1276
(80 %)
39 diff
(97.0 %id)
TI_927047522   .c 2897 to 3929 52 to 1083       1032/1192
(86 %)
12 diff
(99.0 %id)
TI_927047772   .c 2897 to 4024 62 to 1183       1122/1286
(87 %)
19 diff
(98.6 %id)
TI_2194579577   .c 2899 to 3989 55 to 1140     Submitted on the opposite strand 1086/1259
(86 %)
12 diff
(99.1 %id)
CV026815 mixed .c 2966 to 3276 1 to 312       312/312
(100 %)
18 diff
(94.3 %id)
DB278049 uterus .c 3012 to 3528 2 to 519   capped   518/518
(100 %)
1 diff
(99.9 %id)
CD619102   .c 3229 to 3575 1 to 346       346/365
(94 %)
4 diff
(99.0 %id)
CD619103   .c 3229 to 3575 366 to 20       347/366
(94 %)
0 diff
(100 %id)
BQ326458 colon_normal .c 3288 to 3740 482 to 32       451/483
(93 %)
7 diff
(98.6 %id)
BE872155 adenocarcinoma, colon .c 3322 to 3782 1 to 462       462/798
(57 %)
3 diff
(99.7 %id)
BG984045 colon_normal .c 3429 to 3918 490 to 1       490/491
(99 %)
0 diff
(100 %id)
DB094517 testis .c 3429 to 3981 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BF757617 colon .c 3477 to 3993 3 to 521       519/521
(99 %)
16 diff
(97.0 %id)
DA741167   .c 3536 to 4050 2 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
BF812711 colon_ins .c 3602 to 4039 34 to 471       438/471
(92 %)
7 diff
(98.6 %id)
CR933657 seminom .d 1 to 4256 1 to 4256 P50S C551S tiling clone, AAA   4256/4256
(100 %)
7 diff
(99.9 %id)
DA754981   .d 1 to 537 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
BM468571 leiomyosarcoma, uterus .d 13 to 1007 1 to 1003       1003/1086
(92 %)
32 diff
(97.1 %id)
BP228711 brain .d 26 to 607 1 to 582       582/582
(100 %)
0 diff
(100 %id)
NM_004655.3   .d 26 to 4255 1 to 4230 exact RefSeq, AAA   4230/4230
(100 %)
0 diff
(100 %id)
DA785881 brain .d 27 to 607 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DR000103 fetal brain .d 27 to 546 1 to 519       519/519
(100 %)
3 diff
(99.5 %id)
BX340810   .d 60 to 1014 1 to 950       950/950
(100 %)
11 diff
(98.9 %id)
DA510345 brain .d 79 to 667 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DR002800 fetal brain .d 104 to 653 7 to 556       550/556
(98 %)
10 diff
(98.3 %id)
AK315303 brain .d 108 to 2846 1 to 2737 E184K N185C A186L Y187P Q188D ...     2737/2737
(100 %)
6 diff
(99.8 %id)
DA242620 brain .d 109 to 697 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA754607   .d 109 to 598 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DA788156 brain .d 109 to 638 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
BI913880 brain .d 114 to 905 1 to 791       791/791
(100 %)
1 diff
(99.9 %id)
TI_57243445   .d 114 to 905 30 to 820       791/820
(96 %)
7 diff
(99.2 %id)
DB460771 testis .d 117 to 501 1 to 385       385/385
(100 %)
1 diff
(99.8 %id)
DA924085 small intestine .d 129 to 703 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DR157737 human embryonic stem cells differentiated toan early endodermal cell type .d 146 to 596 1 to 451       451/451
(100 %)
1 diff
(99.8 %id)
AF078165   .d 226 to 3296 1 to 3072 P50S     3072/3072
(100 %)
6 diff
(99.9 %id)
BC101533 Brain, cerebral cortex, PCR rescued clones .d 246 to 2862 1 to 2617 P50S     2617/2617
(100 %)
3 diff
(99.9 %id)
TI_927047407   .d 713 to 1887 7 to 1165       1159/1268
(91 %)
33 diff
(97.4 %id)
TI_927047408   .d 842 to 1992 1 to 1139       1139/1243
(91 %)
16 diff
(98.8 %id)
TI_2194578822   .d 850 to 1982 9 to 1135       1127/1264
(89 %)
15 diff
(98.9 %id)
BX369419   .d 853 to 1708 1 to 854       854/927
(92 %)
14 diff
(98.5 %id)
DB152124 thymus .d 941 to 1526 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
CN302753 embryonic stem cells, cell lines H1, H7, andH9 .d 950 to 1547 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
DA863680 placenta .d 975 to 1551 2 to 578   capped   577/581
(99 %)
1 diff
(99.9 %id)
AK025718   .d 1004 to 3098 1 to 2095   tiling clone, available from FLJ,   2095/2104
(99 %)
3 diff
(99.9 %id)
CN302752 embryonic stem cells, cell lines H1, H7, andH9 .d 1016 to 1548 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
DB149553 thymus .d 1042 to 1520 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
AA489748 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1052 to 1404 1 to 353   fully sequenced,   353/353
(100 %)
2 diff
(99.5 %id)
BM543373 duodenal adenocarcinoma, cell line, small intestine .d 1094 to 1792 1 to 705       705/1101
(64 %)
17 diff
(98.5 %id)
AI818109 anaplastic oligodendroglioma, brain .d 1159 to 1748 590 to 1       590/591
(99 %)
5 diff
(99.2 %id)
TI_927047409   .d 1174 to 2462 1 to 1274       1274/1294
(98 %)
17 diff
(98.7 %id)
DA054210 cerebellum .d 1206 to 1690 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
AI220032 pooled .d 1206 to 1748 543 to 1       543/543
(100 %)
4 diff
(99.3 %id)
AA937585 adenocarcinoma, colon .d 1283 to 1730 444 to 1       444/444
(100 %)
7 diff
(98.5 %id)
DA747295   .d 1294 to 1775 2 to 483   capped   482/482
(100 %)
1 diff
(99.8 %id)
AI272864 adenocarcinoma, colon .d 1302 to 1761 459 to 1       459/459
(100 %)
3 diff
(99.4 %id)
AI307112 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1302 to 1789 487 to 1       487/487
(100 %)
6 diff
(98.8 %id)
AI419942 pooled .d 1302 to 1761 460 to 1       460/460
(100 %)
7 diff
(98.5 %id)
AA489644 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1343 to 1752 408 to 1   fully sequenced,   408/408
(100 %)
8 diff
(98.1 %id)
AI858567 anaplastic oligodendroglioma, brain .d 1344 to 1761 418 to 1       418/418
(100 %)
9 diff
(97.9 %id)
AA884421 pooled .d 1356 to 1752 391 to 1       391/391
(100 %)
10 diff
(97.5 %id)
TI_927047955   .d 1470 to 2591 1125 to 6       1120/1234
(90 %)
16 diff
(98.8 %id)
TI_927047402   .d 1526 to 2630 1 to 1091       1093/1242
(88 %)
22 diff
(98.3 %id)
DA839648 placenta .d 1549 to 2100 2 to 553   tiling clone, capped   552/552
(100 %)
3 diff
(99.5 %id)
AW474251 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1573 to 1789 218 to 2       217/222
(97 %)
0 diff
(100 %id)
AW172276 pooled .d 1578 to 1758 181 to 1       181/181
(100 %)
3 diff
(98.4 %id)
BM925216 pooled lung and spleen .d 1610 to 1781 9 to 181       173/181
(95 %)
6 diff
(96.7 %id)
TI_927047954   .d 1722 to 2851 1120 to 1       1120/1247
(89 %)
26 diff
(98.0 %id)
TI_927047773   .d 1787 to 2869 1111 to 41       1071/1239
(86 %)
9 diff
(99.3 %id)
TI_927047617   .d 1793 to 2869 1138 to 69       1070/1214
(88 %)
17 diff
(98.6 %id)
AI912345 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1802 to 2264 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AA903395 pooled germ cell tumors .d 1833 to 2284 1 to 447     Submitted on the opposite strand 447/447
(100 %)
9 diff
(98.0 %id)
AI262837 adenocarcinoma, colon .d 1833 to 2196 1 to 363     Submitted on the opposite strand 363/363
(100 %)
5 diff
(98.7 %id)
BG824289 adenocarcinoma cell line, colon .d 1837 to 2337 1 to 507       507/923
(54 %)
14 diff
(98.5 %id)
TI_927047403   .d 1878 to 2869 1 to 991       991/1272
(77 %)
6 diff
(99.6 %id)
TI_927046362   .d 1915 to 2869 1088 to 132       957/1088
(87 %)
13 diff
(98.9 %id)
TI_927047022   .d 2033 to 2869 964 to 126       839/966
(86 %)
22 diff
(97.8 %id)
BE882875 leiomyosarcoma, uterus .d 2082 to 2804 1 to 726       726/732
(99 %)
29 diff
(96.1 %id)
AA305361 colon .d 2117 to 2491 1 to 375       375/375
(100 %)
3 diff
(99.2 %id)
AW962356   .d 2118 to 2735 1 to 621       621/621
(100 %)
10 diff
(98.4 %id)
CN388942 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 2235 to 2604 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BM474589 leiomyosarcoma, uterus .d 2359 to 3292 1 to 949       949/1027
(92 %)
22 diff
(97.9 %id)
BP293188 lung .d 2381 to 2961 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP293526 lung .d 2381 to 2959 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
BP376354 uterus .d 2383 to 2963 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
AA446378   .d 2400 to 2941 7 to 548       542/548
(98 %)
6 diff
(99.0 %id)
AB052751   .d 2401 to 4259 1 to 1858       1858/1863
(99 %)
5 diff
(99.8 %id)
BM473985 leiomyosarcoma, uterus .d 2519 to 3162 1 to 648       648/1004
(64 %)
18 diff
(98.3 %id)
TI_2194578819   .d 2533 to 2869 15 to 351       337/1281
(26 %)
7 diff
(99.5 %id)
CX752082 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 2552 to 3242 11 to 701     Submitted on the opposite strand 690/701
(98 %)
10 diff
(98.6 %id)
BM745159 Ascites, stomach .d 2555 to 3055 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BM770270 Ascites, stomach .d 2555 to 3143 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BM771508 Ascites, stomach .d 2555 to 3001 1 to 447       447/447
(100 %)
0 diff
(100 %id)
DB518980 testis .d 2630 to 3098 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
CX759580 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 2646 to 3362 1 to 717     Submitted on the opposite strand 717/717
(100 %)
0 diff
(100 %id)
CB990393 Human Placenta, placenta .d 2779 to 3273 27 to 523       497/960
(51 %)
6 diff
(99.4 %id)
BG999766 head_normal .d 2780 to 3142 12 to 372       361/372
(97 %)
6 diff
(98.4 %id)
BM472979 duodenal adenocarcinoma, cell line, small intestine .d 2859 to 3731 13 to 899       887/1017
(87 %)
22 diff
(97.9 %id)
DB520598 testis .d 2902 to 3098 10 to 208     Submitted on the opposite strand 199/208
(95 %)
6 diff
(97.2 %id)
AA325695 brain, cerebellum .d 2952 to 3296 1 to 346       346/346
(100 %)
2 diff
(99.5 %id)
CX761767 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 2973 to 3656 1 to 685     Submitted on the opposite strand 685/685
(100 %)
1 diff
(99.9 %id)
CB216754 normal endometrium, mid-secretory phase,cycle day 23, uterus .d 2978 to 3609 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
BQ064642 lymph, lymphoma, cell line .d 3023 to 4019 1 to 1006       1006/1105
(91 %)
50 diff
(95.5 %id)
CX756263 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 3027 to 3758 1 to 732   tiling clone, Submitted on the opposite strand 732/732
(100 %)
0 diff
(100 %id)
BQ644931 hepatocellular carcinoma, cell line, Liver .d 3028 to 3640 1 to 617       617/1007
(61 %)
8 diff
(99.3 %id)
CX165641 human embryonic stem cells differentiated toan early endodermal cell type .d 3042 to 3821 1 to 779       779/779
(100 %)
1 diff
(99.9 %id)
BF686233 leiomyosarcoma cell line, uterus .d 3047 to 3709 1 to 660       660/836
(78 %)
30 diff
(96.5 %id)
BF756552 colon .d 3069 to 3393 331 to 7     Submitted on the opposite strand 325/331
(98 %)
0 diff
(100 %id)
R51262 whole brain .d 3072 to 3478 409 to 1     Submitted on the opposite strand 409/411
(99 %)
13 diff
(96.9 %id)
H95839 liver and spleen .d 3072 to 3343 1 to 278       278/280
(99 %)
9 diff
(96.8 %id)
AA341377 Kidney .d 3126 to 3424 1 to 300       300/305
(98 %)
5 diff
(98.4 %id)
FN059167 breast carcinoma .d 3127 to 3191 65 to 1     Submitted on the opposite strand 65/66
(98 %)
0 diff
(100 %id)
BQ652228 hepatocellular carcinoma, cell line, Liver .d 3141 to 3920 18 to 803       786/851
(92 %)
12 diff
(98.6 %id)
CN278851 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 3157 to 3835 13 to 690       678/690
(98 %)
6 diff
(99.2 %id)
BU941547 mixed (pool of 40 RNAs) .d 3203 to 3931 1 to 735       735/799
(91 %)
23 diff
(97.2 %id)
TI_149315837   .d 3280 to 4255 1046 to 84   AAA   963/1032
(93 %)
19 diff
(98.2 %id)
CN291318 embryonic stem cells, DMSO-treated H9 cellline .d 3305 to 3449 1 to 145       145/145
(100 %)
4 diff
(97.3 %id)
BQ646753 hepatocellular carcinoma, cell line, Liver .d 3330 to 3937 1 to 606       606/889
(68 %)
25 diff
(97.2 %id)
TI_159724038   .d 3345 to 4255 979 to 78   AAA   902/1023
(88 %)
15 diff
(98.6 %id)
BQ438096 leiomyosarcoma, uterus .d 3404 to 4252 849 to 1     Submitted on the opposite strand 849/849
(100 %)
2 diff
(99.8 %id)
TI_151733789   .d 3456 to 4255 877 to 79   AAA   799/1012
(78 %)
9 diff
(99.2 %id)
BQ187115 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 3458 to 3906 1 to 448   fully sequenced,   448/448
(100 %)
2 diff
(99.6 %id)
BQ428398 leiomyosarcoma, uterus .d 3492 to 4259 803 to 28   tiling clone, Submitted on the opposite strand 776/892
(86 %)
0 diff
(100 %id)
AI697890 carcinoid, lung .d 3506 to 4026 1 to 521     Submitted on the opposite strand 521/521
(100 %)
2 diff
(99.7 %id)
FN118198 breast carcinoma .d 3508 to 3612 1 to 109       109/110
(99 %)
5 diff
(95.5 %id)
BU600360 mixed (pool of 40 RNAs) .d 3535 to 4254 1 to 729       729/796
(91 %)
25 diff
(96.9 %id)
TI_149292556   .d 3547 to 4255 785 to 77   AAA   709/709
(100 %)
4 diff
(99.5 %id)
TI_149292785   .d 3551 to 4255 784 to 81   AAA   704/706
(99 %)
10 diff
(98.6 %id)
CA944713 Human Lung Epithelial cells, lung .d 3564 to 4255 710 to 19   AAA   692/692
(100 %)
1 diff
(99.9 %id)
CX761909 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 3595 to 4259 670 to 6       665/670
(99 %)
0 diff
(100 %id)
BF684446 leiomyosarcoma cell line, uterus .d 3597 to 4255 1 to 656   AAA   656/656
(100 %)
8 diff
(98.8 %id)
BM993271 lung, Metastatic Chondrosarcoma .d 3598 to 4260 676 to 14   AAA   663/663
(100 %)
1 diff
(99.9 %id)
BM974639 lung .d 3598 to 4255 676 to 19   AAA   658/658
(100 %)
1 diff
(99.9 %id)
CB306601 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 3613 to 4255 661 to 19   AAA   643/643
(100 %)
0 diff
(100 %id)
BQ005585 Chondrosarcoma, Left Pelvis .d 3634 to 4188 573 to 19   AAA   555/555
(100 %)
8 diff
(98.6 %id)
BM974846 lung .d 3660 to 4255 614 to 19   AAA   596/596
(100 %)
0 diff
(100 %id)
AI660889 colon, colonic mucosa from 5 ulcerative colitispatients .d 3674 to 4256 583 to 1       583/583
(100 %)
3 diff
(99.5 %id)
CD386771 embryonic trophoblasts, made from WA01 stemcells .d 3679 to 4256 21 to 604   AAA   584/604
(96 %)
6 diff
(99.1 %id)
AA917337 adenocarcinoma, colon .d 3693 to 4259 570 to 5       566/570
(99 %)
0 diff
(100 %id)
AA928690 adenocarcinoma, colon .d 3694 to 4255 562 to 1       562/562
(100 %)
1 diff
(99.9 %id)
BE502564 pooled germ cell tumors .d 3705 to 4257 553 to 1       553/659
(83 %)
1 diff
(99.9 %id)
AI147484 heart .d 3708 to 4259 554 to 3       552/554
(99 %)
0 diff
(100 %id)
AI934466 anaplastic oligodendroglioma, brain .d 3708 to 4258 549 to 1       549/549
(100 %)
1 diff
(99.9 %id)
CF456815 peripheral nervous system .d 3715 to 4256 28 to 569       542/573
(94 %)
2 diff
(99.7 %id)
BE670767 carcinoid, lung .d 3725 to 4255 542 to 12   AAA   531/531
(100 %)
0 diff
(100 %id)
AI401621 brain, glioblastoma (pooled) .d 3742 to 4255 514 to 1       514/514
(100 %)
1 diff
(99.9 %id)
AI961360 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 3742 to 4259 520 to 2       519/520
(99 %)
0 diff
(100 %id)
AW440544 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 3742 to 4255 514 to 1       514/514
(100 %)
1 diff
(99.9 %id)
FN176894 breast carcinoma .d 3743 to 3812 1 to 69       69/69
(100 %)
2 diff
(97.2 %id)
AA976642 carcinoid, lung .d 3749 to 4231 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
AA921892 pooled .d 3757 to 4258 502 to 1       502/502
(100 %)
0 diff
(100 %id)
AI825843 colon, colon tumor, RER+ .d 3769 to 4256 510 to 23   AAA   488/489
(99 %)
27 diff
(94.5 %id)
AA834412 adenocarcinoma, colon .d 3779 to 4127 349 to 1       349/349
(100 %)
1 diff
(99.8 %id)
AW009558 colon .d 3788 to 4256 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AW009577 colon .d 3788 to 4256 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
AW117268 pooled .d 3788 to 4258 471 to 1       471/471
(100 %)
2 diff
(99.6 %id)
BE674170 carcinoid, lung .d 3788 to 4259 474 to 3       472/474
(99 %)
0 diff
(100 %id)
AA772408 parathyroid gland, parathyroid tumor .d 3789 to 4259 475 to 6       470/475
(98 %)
0 diff
(100 %id)
AI630818 carcinoid, lung .d 3789 to 4254 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI348124 adenocarcinoma, colon .d 3794 to 4255 462 to 1       462/462
(100 %)
1 diff
(99.8 %id)
AW514755 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 3794 to 4255 462 to 1       462/462
(100 %)
1 diff
(99.8 %id)
CN278850 embryonic stem cells, cell lines H1, H7, andH9 .d 3796 to 4205 411 to 1     Submitted on the opposite strand 411/411
(100 %)
7 diff
(98.3 %id)
BE219635 carcinoid, lung .d 3796 to 4255 470 to 11   AAA   460/460
(100 %)
1 diff
(99.8 %id)
N50971 multiple sclerosis lesions .d 3799 to 4256 461 to 1       461/464
(99 %)
6 diff
(98.8 %id)
AI346373 adenocarcinoma, colon .d 3800 to 4255 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
FN088818 breast carcinoma .d 3801 to 3903 1 to 98       98/102
(96 %)
5 diff
(95.1 %id)
AI273406 adenocarcinoma, colon .d 3801 to 4255 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
BF110936 carcinoid, lung .d 3805 to 4259 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
BF061680 fibrotheoma, ovary .d 3811 to 4255 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
DB518318 testis .d 3815 to 4255 1 to 441     Submitted on the opposite strand 441/441
(100 %)
2 diff
(99.6 %id)
AI279470 carcinoid, lung .d 3815 to 4259 448 to 4       445/448
(99 %)
0 diff
(100 %id)
AA604626 adrenal adenoma, adrenal gland .d 3817 to 4022 206 to 1       206/206
(100 %)
0 diff
(100 %id)
AA932035 carcinoid, lung .d 3826 to 4257 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI285036 adenocarcinoma, colon .d 3826 to 4255 430 to 1       430/430
(100 %)
1 diff
(99.8 %id)
AI304839 adenocarcinoma, colon .d 3826 to 4256 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AA861055   .d 3828 to 4258 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AI285209 adenocarcinoma, colon .d 3832 to 4255 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
AI336472 adenocarcinoma, colon .d 3833 to 4255 423 to 1       423/423
(100 %)
1 diff
(99.8 %id)
DB526171 testis .d 3834 to 4253 1 to 420     Submitted on the opposite strand 420/422
(99 %)
2 diff
(99.6 %id)
AI277100 adenocarcinoma, colon .d 3838 to 4255 417 to 1       417/417
(100 %)
2 diff
(99.6 %id)
AI280184 adenocarcinoma, colon .d 3848 to 4255 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
AI346632 adenocarcinoma, colon .d 3848 to 4237 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
AI024641   .d 3849 to 4258 410 to 1       410/410
(100 %)
0 diff
(100 %id)
DB514729 testis .d 3850 to 4253 1 to 403     Submitted on the opposite strand 403/405
(99 %)
4 diff
(99.1 %id)
AI263962 adenocarcinoma, colon .d 3860 to 4255 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AI276803 adenocarcinoma, colon .d 3861 to 4255 394 to 1       394/394
(100 %)
1 diff
(99.8 %id)
CK300336 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 3876 to 4255 398 to 19   fully sequenced, AAA   380/380
(100 %)
0 diff
(100 %id)
AI262494 adenocarcinoma, colon .d 3881 to 4255 376 to 1       376/376
(100 %)
5 diff
(98.7 %id)
AW592743 pooled .d 3888 to 4254 368 to 1       368/368
(100 %)
5 diff
(98.7 %id)
AA972819 pooled .d 3891 to 4254 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AI312729 lung .d 3894 to 4258 365 to 1       365/365
(100 %)
2 diff
(99.5 %id)
AW016690   .d 3906 to 4255 368 to 18   AAA   351/352
(99 %)
1 diff
(99.8 %id)
F11706 brain, total brain .d 3911 to 4252 345 to 4       342/345
(99 %)
0 diff
(100 %id)
AW779070 pooled .d 3923 to 4258 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI672742 thymus, pooled .d 3937 to 4255 339 to 21   AAA   319/319
(100 %)
2 diff
(99.4 %id)
BE047770 brain, tumor, 5 pooled (see description) .d 3941 to 4227 1 to 287       287/287
(100 %)
3 diff
(99.0 %id)
AI925107 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 3946 to 4259 316 to 3       314/316
(99 %)
0 diff
(100 %id)
AA573711   .d 3947 to 4259 318 to 6       313/322
(97 %)
0 diff
(100 %id)
AA918343 adenocarcinoma, colon .d 3947 to 4255 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AA877565 colon, colon tumor RER+ .d 3956 to 4256 301 to 1       301/301
(100 %)
1 diff
(99.7 %id)
BP392875 pancreatic islet .d 3965 to 4255 1 to 291     Submitted on the opposite strand 291/291
(100 %)
0 diff
(100 %id)
H95840 liver and spleen .d 3993 to 4256 275 to 7       269/332
(81 %)
0 diff
(100 %id)
AI867650 Prostate .d 4007 to 4259 255 to 3       253/255
(99 %)
0 diff
(100 %id)
AI824380 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 4019 to 4257 239 to 1       239/239
(100 %)
0 diff
(100 %id)
CN293726 embryonic stem cells, DMSO-treated H9 cellline .d 4066 to 4240 175 to 1     Submitted on the opposite strand 175/175
(100 %)
0 diff
(100 %id)
AA897688 pooled .d 4076 to 4247 172 to 1       172/172
(100 %)
0 diff
(100 %id)
CN281489 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1 to 404 1 to 404   tiling clone,   404/404
(100 %)
2 diff
(99.6 %id)
BF127420 leiomyosarcoma cell line, uterus .e 26 to 746 1 to 710   tiling clone, available from MGC,   710/758
(93 %)
17 diff
(97.8 %id)
BF983463 duodenal adenocarcinoma, cell line, small intestine .e 37 to 768 11 to 735   tiling clone,   725/996
(72 %)
44 diff
(95.6 %id)
BM562082 leukocyte .e 38 to 1068 20 to 1057   tiling clone,   1038/1061
(97 %)
38 diff
(96.5 %id)
BE883131 leiomyosarcoma, uterus .e 44 to 663 1 to 612       612/618
(99 %)
17 diff
(97.3 %id)
AF205888 brain; lymphoblast .e 388 to 2928 1 to 2538 Q37H P38H V40G G41Q K42G ... tiling clone,   2538/2538
(100 %)
15 diff
(99.5 %id)
BC143244 Brain, cerebral cortex, PCR rescued clones .e 428 to 2853 1 to 2426 P50S tiling clone,   2426/2426
(100 %)
4 diff
(99.9 %id)
TI_2194578823   .e 1355 to 2505 1 to 1144       1144/1270
(90 %)
19 diff
(98.6 %id)
TI_2194579576   .e 1705 to 2856 1185 to 44   tiling clone, Submitted on the opposite strand 1142/1270
(89 %)
21 diff
(98.4 %id)
TI_2194578817   .e 1714 to 2856 10 to 1146       1137/1230
(92 %)
16 diff
(98.7 %id)
AI383206 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2014 to 2321 1 to 310     Submitted on the opposite strand 310/310
(100 %)
12 diff
(96.2 %id)
AA502360 colon .e 2015 to 2445 1 to 428     Submitted on the opposite strand 428/428
(100 %)
4 diff
(99.1 %id)
BF436343 fibrotheoma, ovary .e 2015 to 2353 1 to 345     Submitted on the opposite strand 345/345
(100 %)
5 diff
(98.6 %id)
TI_2194578818   .e 2065 to 2856 7 to 798       792/1259
(62 %)
7 diff
(99.5 %id)
DA581405 lung .f 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
AK098070 trachea .f 381 to 2360 1 to 1980   tiling clone, available from FLJ,   1980/1980
(100 %)
2 diff
(99.9 %id)
BI488624 brain .g 1 to 870 1 to 876   tiling clone, fully sequenced,   876/876
(100 %)
23 diff
(97.4 %id)
TI_45379227   .g 1 to 870 66 to 941   fully sequenced,   876/941
(93 %)
29 diff
(97.0 %id)
BI489101 brain .g 840 to 1671 828 to 1   tiling clone, fully sequenced,   828/828
(100 %)
14 diff
(98.4 %id)
TI_45379228   .g 840 to 1679 884 to 49   tiling clone, fully sequenced,   836/884
(94 %)
12 diff
(98.7 %id)
BG717609 testis .h 1 to 572 1 to 571   tiling clone,   571/571
(100 %)
6 diff
(99.0 %id)
DA156389 amygdala .h 296 to 874 2 to 581   tiling clone, capped   580/580
(100 %)
2 diff
(99.7 %id)
BX358608 Placenta Cot 25-normalized .i 1 to 978 1 to 977 V248X G249X T264R E265K T266L ... tiling clone,   977/977
(100 %)
3 diff
(99.7 %id)
BI562313 testis .j 1 to 636 1 to 636   tiling clone, available from MGC,   636/803
(79 %)
14 diff
(98.3 %id)
BC029524 testis .j 6 to 1035 1 to 1030 exact tiling clone, available from MGC, AAA   1030/1030
(100 %)
0 diff
(100 %id)
TI_44350212   .j 6 to 636 130 to 760       631/927
(68 %)
16 diff
(98.3 %id)
NM_001037325.2   .j 6 to 1322 1 to 1317 exact RefSeq,   1317/1318
(99 %)
5 diff
(99.7 %id)
DB453265 testis .j 98 to 599 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
BP370779 testis .j 98 to 626 1 to 529       529/575
(92 %)
5 diff
(99.2 %id)
BM552855 brain, medulla .j 112 to 1036 14 to 945 Q177T S185L K187X R210Q R211K     932/974
(95 %)
25 diff
(97.5 %id)
EG328111 pooled .j 357 to 717 369 to 8     Submitted on the opposite strand 362/369
(98 %)
1 diff
(99.8 %id)
DB109640 thymus .k 1 to 587 2 to 588 E112* tiling clone, capped   587/587
(100 %)
2 diff
(99.7 %id)
BJ992147 hepatoblastoma .k 57 to 464 1 to 408   tiling clone,   408/408
(100 %)
0 diff
(100 %id)
BP369767 testis .l 1 to 577 1 to 577 exact tiling clone,   577/577
(100 %)
0 diff
(100 %id)
DA105935 cerebellum .m 1 to 545 2 to 544   tiling clone, capped   543/543
(100 %)
2 diff
(99.7 %id)
EG327980 pooled .m 299 to 751 453 to 1     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
EG327425 pooled .m 304 to 751 448 to 1     Submitted on the opposite strand 448/448
(100 %)
0 diff
(100 %id)
EG327373 pooled .m 312 to 775 463 to 1   tiling clone, Submitted on the opposite strand 463/463
(100 %)
3 diff
(99.4 %id)
EG327372 pooled .m 352 to 805 1 to 454       454/454
(100 %)
14 diff
(97.0 %id)
CV575632 cornea, eye .m 723 to 1359 1 to 637   tiling clone,   637/637
(100 %)
0 diff
(100 %id)
AI660139 thymus, pooled .n 1 to 410 408 to 1   tiling clone,   408/408
(100 %)
6 diff
(98.6 %id)
AI336613 adenocarcinoma, colon .n 25 to 438 413 to 1   tiling clone,   413/413
(100 %)
5 diff
(98.8 %id)
CN302754 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 51 to 467 1 to 417   tiling clone,   417/417
(100 %)
2 diff
(99.6 %id)
AW207598   .n 59 to 437 377 to 1       377/383
(98 %)
6 diff
(98.5 %id)
AI742962 pooled .n 66 to 410 345 to 1   tiling clone,   345/345
(100 %)
1 diff
(99.8 %id)
AI363868 anaplastic oligodendroglioma, brain .n 100 to 397 299 to 1       299/299
(100 %)
6 diff
(98.0 %id)
DB452863 testis .o 1 to 426 1 to 428 A112G P113A A114C R115E S116V ... tiling clone,   428/428
(100 %)
13 diff
(97.0 %id)
CR982812 T-Lymphocytes .o 11 to 584 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BX395620 Placenta Cot 25-normalized .o 36 to 1023 1 to 979   tiling clone,   979/1017
(96 %)
20 diff
(98.1 %id)
BI907056 leukocyte .o 250 to 932 1 to 695   tiling clone,   695/695
(100 %)
26 diff
(96.3 %id)
TI_57233607   .o 251 to 932 39 to 732       694/732
(94 %)
20 diff
(97.3 %id)
AK097612 testis .p 1 to 1706 2 to 1708 I27V tiling clone, available from FLJ,   1708/1708
(100 %)
3 diff
(99.9 %id)
DB041495 testis .p 1 to 559 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB337878 testis .p 1170 to 1706 537 to 1       537/537
(100 %)
0 diff
(100 %id)
BX482054   .p 1312 to 1961 1 to 651   tiling clone,   651/655
(99 %)
3 diff
(99.6 %id)
AW274406 pooled .p 1316 to 1692 379 to 3       377/379
(99 %)
0 diff
(100 %id)
DB152697 thymus .q 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BE551545 pooled germ cell tumors .r 1 to 522 524 to 3 exact tiling clone,   522/524
(99 %)
0 diff
(100 %id)
BE465949 pooled germ cell tumors .r 31 to 522 494 to 3       492/494
(99 %)
0 diff
(100 %id)
AI638404 pooled germ cell tumors .r 35 to 522 490 to 3       488/490
(99 %)
0 diff
(100 %id)
AI631200 pooled germ cell tumors .r 66 to 522 459 to 3       457/459
(99 %)
0 diff
(100 %id)
BE502659 pooled germ cell tumors .r 66 to 522 459 to 3       457/459
(99 %)
0 diff
(100 %id)
BG216120   .s 1 to 458 23 to 482 K2X Q3X I4S E5M K6X ... tiling clone, AAA   460/482
(95 %)
9 diff
(98.2 %id)
AA460208   .t 1 to 275 1 to 275   tiling clone, fully sequenced,   275/275
(100 %)
2 diff
(99.3 %id)
AA459933   .t 245 to 519 275 to 1   tiling clone, fully sequenced,   275/275
(100 %)
0 diff
(100 %id)
DR000606 fetal brain .u 1 to 620 8 to 627 exact tiling clone,   621/629
(98 %)
7 diff
(98.9 %id)
BP349799 brain .va 1 to 581 1 to 582 E52G tiling clone,   582/582
(100 %)
4 diff
(99.4 %id)
DB037154 testis .vb 1 to 571 2 to 573   tiling clone, capped   572/572
(100 %)
3 diff
(99.5 %id)
DB453509 testis .vb 32 to 525 1 to 494   tiling clone,   494/494
(100 %)
2 diff
(99.6 %id)
DB455189 testis .vb 32 to 515 1 to 484       484/484
(100 %)
2 diff
(99.6 %id)
DB341649 testis .vc 1 to 547 547 to 1 C52R tiling clone,   547/547
(100 %)
1 diff
(99.9 %id)
AI819755 2 pooled tumors (clear cell type), Kidney .vd 1 to 516 519 to 4 exact tiling clone,   516/519
(99 %)
0 diff
(100 %id)
BE645814 Prostate .ve 1 to 508 511 to 4 exact tiling clone,   508/511
(99 %)
1 diff
(99.9 %id)
BX956772   .vf-u 1 to 427 1 to 427 exact tiling clone,   427/427
(100 %)
0 diff
(100 %id)
AI476428 pooled .vg 1 to 279 281 to 3 exact tiling clone,   279/281
(99 %)
0 diff
(100 %id)
TI_2194578821   Gene CCDC46andAXIN2, variant not shown         Suspected internal deletion, this clone was ignored    
BE926588 breast Gene CCDC46andAXIN2, variant not shown         Suspected internal deletion, this clone was ignored    
BQ638519 eye, retina Gene CCDC46andAXIN2, variant not shown              
AA102116   Gene CCDC46andAXIN2, variant not shown              
AW104413 pooled Gene CCDC46andAXIN2, variant not shown         Suspected internal deletion, this clone was ignored    
BC006295 Uterus, leiomyosarcoma Gene CCDC46andAXIN2, variant not shown       available from MGC, AAA This clone was ignored    
DA722227   Gene CCDC46andAXIN2, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB326588 brain Gene CCDC46andAXIN2, variant not shown         This clone was ignored    
DA791635 brain Gene CCDC46andAXIN2, variant not shown       capped This clone was ignored    
DA804948 brain Gene CCDC46andAXIN2, variant not shown       capped Suspected internal deletion, this clone was ignored    
TI_1948152438   Gene CCDC46andAXIN2, variant not shown         This clone was ignored    
TI_1948152439   Gene CCDC46andAXIN2, variant not shown         This clone was ignored    
TI_1948152713   Gene CCDC46andAXIN2, variant not shown         This clone was ignored    
TI_1948152714   Gene CCDC46andAXIN2, variant not shown         This clone was ignored    
DB047111 testis Gene CCDC46andAXIN2, variant not shown       capped      
DB338284 testis Gene CCDC46andAXIN2, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf-u, .vg Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI